{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:41:36Z","timestamp":1792928496582,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T00:00:00Z","timestamp":1508284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T00:00:00Z","timestamp":1508284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diabetic cardiomyopathy is characterized by metabolic changes in the myocardium that promote a slow and silent dysfunction of muscle fibers, leading to myocardium remodelling and heart failure, independently of the presence of coronary artery diseases or hypertension. At present, no imaging methods allow an early diagnosis of this disease. Circulating miRNAs in plasma have been proposed as biomarkers in the prognosis of several cardiac diseases. This study aimed to determine whether circulating miRNAs could be potential biomarkers of diabetic cardiomyopathy. Mice that were fed with a high fat diet for 16 months, showed metabolic syndrome manifestations, cardiac hypertrophy (without hypertension) and a progressive cardiac function decline. At 16 months, when maximal degree of cardiac dysfunction was observed, 15 miRNAs from a miRNA microarray screening in myocardium were selected. Then, selected miRNAs expression in myocardium (at 4 and 16 months) and plasma (at 4, 12 and 16 months) were measured by RT-qPCR. Circulating miR-19b-3p and miR-181b-5p levels were associated with myocardium levels during the development of diabetic cardiomyopathy (in terms of cardiac dysfunction), suggesting that these miRNAs could be suitable biomarkers of this disease in asymptomatic diabetic patients.<\/jats:p>","DOI":"10.1038\/s41598-017-13875-2","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T15:25:58Z","timestamp":1507821958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy"],"prefix":"10.1038","volume":"7","author":[{"given":"Camila Uribe","family":"Copier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Contador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n D.","family":"Calligaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,18]]},"reference":[{"key":"13875_CR1","unstructured":"Global Report on Diabetes. (World Health Organization, 2016)."},{"key":"13875_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler, S. et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol \n                           30, 595\u2013602 (1972).","journal-title":"Am J Cardiol"},{"key":"13875_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","volume":"11","author":"S Boudina","year":"2010","unstructured":"Boudina, S. & Abel, E. D. Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord \n                           11, 31\u201339, https:\/\/doi.org\/10.1007\/s11154-010-9131-7 (2010).","journal-title":"Rev Endocr Metab Disord"},{"key":"13875_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4070\/kcj.2015.45.4.266","volume":"45","author":"S Yilmaz","year":"2015","unstructured":"Yilmaz, S., Canpolat, U., Aydogdu, S. & Abboud, H. E. Diabetic Cardiomyopathy; Summary of 41 Years. Korean Circ J \n                           45, 266\u2013272, https:\/\/doi.org\/10.4070\/kcj.2015.45.4.266 (2015).","journal-title":"Korean Circ J"},{"key":"13875_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cardfail.2014.02.007","volume":"20","author":"S Dandamudi","year":"2014","unstructured":"Dandamudi, S. et al. The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota. J Card Fail \n                           20, 304\u2013309, https:\/\/doi.org\/10.1016\/j.cardfail.2014.02.007 (2014).","journal-title":"J Card Fail"},{"key":"13875_CR6","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/eurjhf\/hfq110","volume":"12","author":"S Kiencke","year":"2010","unstructured":"Kiencke, S. et al. Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcome. Eur J Heart Fail \n                           12, 951\u2013957, https:\/\/doi.org\/10.1093\/eurjhf\/hfq110 (2010).","journal-title":"Eur J Heart Fail"},{"key":"13875_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/DMSO.S30968","volume":"6","author":"V Chavali","year":"2013","unstructured":"Chavali, V., Tyagi, S. C. & Mishra, P. K. Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab Syndr Obes \n                           6, 151\u2013160, https:\/\/doi.org\/10.2147\/DMSO.S30968 (2013).","journal-title":"Diabetes Metab Syndr Obes"},{"key":"13875_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.diabres.2012.03.008","volume":"97","author":"C Teupe","year":"2012","unstructured":"Teupe, C. & Rosak, C. Diabetic cardiomyopathy and diastolic heart failure\u2013difficulties with relaxation. Diabetes Res Clin Pract \n                           97, 185\u2013194, https:\/\/doi.org\/10.1016\/j.diabres.2012.03.008 (2012).","journal-title":"Diabetes Res Clin Pract"},{"key":"13875_CR9","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/emboj.2013.134","volume":"32","author":"JC Scheuermann","year":"2013","unstructured":"Scheuermann, J. C. & Boyer, L. A. Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease. Embo J \n                           32, 1805\u20131816, https:\/\/doi.org\/10.1038\/emboj.2013.134 (2013).","journal-title":"Embo J"},{"key":"13875_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep37354","volume":"6","author":"D de Gonzalo-Calvo","year":"2016","unstructured":"de Gonzalo-Calvo, D. et al. Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes. Sci Rep \n                           6, 37354, https:\/\/doi.org\/10.1038\/srep37354 (2016).","journal-title":"Sci Rep"},{"key":"13875_CR11","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1016\/j.jacc.2016.09.945","volume":"68","author":"T Barwari","year":"2016","unstructured":"Barwari, T., Joshi, A. & Mayr, M. MicroRNAs in Cardiovascular Disease. J Am Coll Cardiol \n                           68, 2577\u20132584, https:\/\/doi.org\/10.1016\/j.jacc.2016.09.945 (2016).","journal-title":"J Am Coll Cardiol"},{"key":"13875_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/aje\/kwu135","volume":"180","author":"VS Nair","year":"2014","unstructured":"Nair, V. S., Pritchard, C. C., Tewari, M. & Ioannidis, J. P. Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies. Am J Epidemiol \n                           180, 140\u2013152, https:\/\/doi.org\/10.1093\/aje\/kwu135 (2014).","journal-title":"Am J Epidemiol"},{"key":"13875_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060931","volume":"8","author":"SD Calligaris","year":"2013","unstructured":"Calligaris, S. D. et al. Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy. PLoS One \n                           8, e60931, https:\/\/doi.org\/10.1371\/journal.pone.0060931 (2013).","journal-title":"PLoS One"},{"key":"13875_CR14","doi-asserted-by":"publisher","unstructured":"Hu, N. & Zhang, Y. TLR4 Knockout Attenuated High Fat Diet-Induced Cardiac Dysfunction via NF-kappaB\/JNK-Dependent Activation of Autophagy. Biochim Biophys Acta, doi:https:\/\/doi.org\/10.1016\/j.bbadis.2017.01.010 (2017).","DOI":"10.1016\/j.bbadis.2017.01.010"},{"key":"13875_CR15","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1111\/jcmm.12556","volume":"19","author":"H Zeng","year":"2015","unstructured":"Zeng, H., Vaka, V. R., He, X., Booz, G. W. & Chen, J. X. High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss. J Cell Mol Med \n                           19, 1847\u20131856, https:\/\/doi.org\/10.1111\/jcmm.12556 (2015).","journal-title":"J Cell Mol Med"},{"key":"13875_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083174","volume":"8","author":"RE Brainard","year":"2013","unstructured":"Brainard, R. E. et al. High fat feeding in mice is insufficient to induce cardiac dysfunction and does not exacerbate heart failure. PLoS One \n                           8, e83174, https:\/\/doi.org\/10.1371\/journal.pone.0083174 (2013).","journal-title":"PLoS One"},{"key":"13875_CR17","doi-asserted-by":"publisher","first-page":"H2134","DOI":"10.1152\/ajpheart.00845.2001","volume":"282","author":"DM Roth","year":"2002","unstructured":"Roth, D. M., Swaney, J. S., Dalton, N. D., Gilpin, E. A. & Ross, J. Jr. Impact of anesthesia on cardiac function during echocardiography in mice. Am J Physiol Heart Circ Physiol \n                           282, H2134\u20132140, https:\/\/doi.org\/10.1152\/ajpheart.00845.2001 (2002).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"13875_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1530\/JOE-16-0377","volume":"233","author":"RL Hull","year":"2017","unstructured":"Hull, R. L. et al. High fat feeding unmasks variable insulin responses in male C57BL\/6 mouse substrains. J Endocrinol \n                           233, 53\u201364, https:\/\/doi.org\/10.1530\/JOE-16-0377 (2017).","journal-title":"J Endocrinol"},{"key":"13875_CR19","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/jcp.25280","volume":"231","author":"EC Guedes","year":"2016","unstructured":"Guedes, E. C. et al. MicroRNA Expression Signature Is Altered in the Cardiac Remodeling Induced by High Fat Diets. J Cell Physiol \n                           231, 1771\u20131783, https:\/\/doi.org\/10.1002\/jcp.25280 (2016).","journal-title":"J Cell Physiol"},{"key":"13875_CR20","doi-asserted-by":"publisher","first-page":"21075","DOI":"10.1073\/pnas.1118922109","volume":"108","author":"RJ Frost","year":"2011","unstructured":"Frost, R. J. & Olson, E. N. Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc Natl Acad Sci USA \n                           108, 21075\u201321080, https:\/\/doi.org\/10.1073\/pnas.1118922109 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"13875_CR21","doi-asserted-by":"publisher","first-page":"E257","DOI":"10.1152\/ajpendo.00348.2014","volume":"308","author":"T Li","year":"2015","unstructured":"Li, T. et al. Diabetes and hyperlipidemia induce dysfunction of VSMCs: contribution of the metabolic inflammation\/miRNA pathway. Am J Physiol Endocrinol Metab \n                           308, E257\u2013269, https:\/\/doi.org\/10.1152\/ajpendo.00348.2014 (2015).","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"13875_CR22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.bbadis.2016.01.010","volume":"1862","author":"A Marchand","year":"2016","unstructured":"Marchand, A. et al. miR-322 regulates insulin signaling pathway and protects against metabolic syndrome-induced cardiac dysfunction in mice. Biochim Biophys Acta \n                           1862, 611\u2013621, https:\/\/doi.org\/10.1016\/j.bbadis.2016.01.010 (2016).","journal-title":"Biochim Biophys Acta"},{"key":"13875_CR23","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/jcmm.12858","volume":"20","author":"C Zhong","year":"2016","unstructured":"Zhong, C. et al. miR-19b controls cardiac fibroblast proliferation and migration. J Cell Mol Med \n                           20, 1191\u20131197, https:\/\/doi.org\/10.1111\/jcmm.12858 (2016).","journal-title":"J Cell Mol Med"},{"key":"13875_CR24","doi-asserted-by":"publisher","unstructured":"Lai, L., Wang, N., Zhu, G., Duan, X. & Ling, F. MiRNA-30e mediated cardioprotection of ACE2 in rats with doxorubicin-induced heart failure through inhibiting cardiomyocytes autophagy. Life Sci, doi:https:\/\/doi.org\/10.1016\/j.lfs.2016.09.006 (2016).","DOI":"10.1016\/j.lfs.2016.09.006"},{"key":"13875_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4161\/rna.28300","volume":"11","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. miR-499 protects cardiomyocytes from H 2O 2-induced apoptosis via its effects on Pdcd4 and Pacs2. RNA Biol \n                           11, 339\u2013350, https:\/\/doi.org\/10.4161\/rna.28300 (2014).","journal-title":"RNA Biol"},{"key":"13875_CR26","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1128\/MCB.00774-13","volume":"34","author":"J Li","year":"2014","unstructured":"Li, J. et al. Mitofusin 1 is negatively regulated by microRNA 140 in cardiomyocyte apoptosis. Mol Cell Biol \n                           34, 1788\u20131799, https:\/\/doi.org\/10.1128\/MCB.00774-13 (2014).","journal-title":"Mol Cell Biol"},{"key":"13875_CR27","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/CIRCRESAHA.108.193102","volume":"104","author":"S Rane","year":"2009","unstructured":"Rane, S. et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res \n                           104, 879\u2013886, https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.193102 (2009).","journal-title":"Circ Res"},{"key":"13875_CR28","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.3390\/ijms16035420","volume":"16","author":"L Pan","year":"2015","unstructured":"Pan, L. et al. MiR-25 protects cardiomyocytes against oxidative damage by targeting the mitochondrial calcium uniporter. Int J Mol Sci \n                           16, 5420\u20135433, https:\/\/doi.org\/10.3390\/ijms16035420 (2015).","journal-title":"Int J Mol Sci"},{"key":"13875_CR29","doi-asserted-by":"publisher","unstructured":"Das, S. et al. Divergent Effects of miR-181 Family Members on Myocardial Function Through Protective Cytosolic and Detrimental Mitochondrial microRNA Targets. J Am Heart Assoc \n                           6, doi:https:\/\/doi.org\/10.1161\/JAHA.116.004694 (2017).","DOI":"10.1161\/JAHA.116.004694"},{"key":"13875_CR30","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1242\/dmm.020768","volume":"8","author":"X Palomer","year":"2015","unstructured":"Palomer, X. et al. miR-146a targets Fos expression in human cardiac cells. Dis Model Mech \n                           8, 1081\u20131091, https:\/\/doi.org\/10.1242\/dmm.020768 (2015).","journal-title":"Dis Model Mech"},{"key":"13875_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s13105-015-0413-0","volume":"71","author":"AM Khamaneh","year":"2015","unstructured":"Khamaneh, A. M., Alipour, M. R., Sheikhzadeh Hesari, F. & Ghadiri Soufi, F. A signature of microRNA-155 in the pathogenesis of diabetic complications. J Physiol Biochem \n                           71, 301\u2013309, https:\/\/doi.org\/10.1007\/s13105-015-0413-0 (2015).","journal-title":"J Physiol Biochem"},{"key":"13875_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tcm.2013.09.002","volume":"24","author":"X Sun","year":"2014","unstructured":"Sun, X., Sit, A. & Feinberg, M. W. Role of miR-181 family in regulating vascular inflammation and immunity. Trends Cardiovasc Med \n                           24, 105\u2013112, https:\/\/doi.org\/10.1016\/j.tcm.2013.09.002 (2014).","journal-title":"Trends Cardiovasc Med"},{"key":"13875_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-016-0901-6","volume":"16","author":"Y Fang","year":"2016","unstructured":"Fang, Y. et al. Burkholderia pseudomallei-derived miR-3473 enhances NF-kappaB via targeting TRAF3 and is associated with different inflammatory responses compared to Burkholderia thailandensis in murine macrophages. BMC Microbiol \n                           16, 283, https:\/\/doi.org\/10.1186\/s12866-016-0901-6 (2016).","journal-title":"BMC Microbiol"},{"key":"13875_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCRESAHA.116.304707","volume":"116","author":"Y Kuwabara","year":"2015","unstructured":"Kuwabara, Y. et al. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1\/AMPK pathway. Circ Res \n                           116, 279\u2013288, https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.304707 (2015).","journal-title":"Circ Res"},{"key":"13875_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep24747","volume":"6","author":"M Zou","year":"2016","unstructured":"Zou, M. et al. Autophagy inhibition of hsa-miR-19a-3p\/19b-3p by targeting TGF-beta R II during TGF-beta1-induced fibrogenesis in human cardiac fibroblasts. Sci Rep \n                           6, 24747, https:\/\/doi.org\/10.1038\/srep24747 (2016).","journal-title":"Sci Rep"},{"key":"13875_CR36","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/eurheartj\/ehv599","volume":"37","author":"S Costantino","year":"2016","unstructured":"Costantino, S., Paneni, F., Luscher, T. F. & Cosentino, F. MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart. Eur Heart J \n                           37, 572\u2013576, https:\/\/doi.org\/10.1093\/eurheartj\/ehv599 (2016).","journal-title":"Eur Heart J"},{"key":"13875_CR37","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.2337\/db08-0079","volume":"57","author":"H Bugger","year":"2008","unstructured":"Bugger, H. et al. Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes \n                           57, 2924\u20132932, https:\/\/doi.org\/10.2337\/db08-0079 (2008).","journal-title":"Diabetes"},{"key":"13875_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174108","volume":"12","author":"D Hori","year":"2017","unstructured":"Hori, D. et al. miR-181b regulates vascular stiffness age dependently in part by regulating TGF-beta signaling. PLoS One \n                           12, e0174108, https:\/\/doi.org\/10.1371\/journal.pone.0174108 (2017).","journal-title":"PLoS One"},{"key":"13875_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12576-012-0230-y","volume":"63","author":"X Jiang","year":"2013","unstructured":"Jiang, X., Ning, Q. & Wang, J. Angiotensin II induced differentially expressed microRNAs in adult rat cardiac fibroblasts. J Physiol Sci \n                           63, 31\u201338, https:\/\/doi.org\/10.1007\/s12576-012-0230-y (2013).","journal-title":"J Physiol Sci"},{"key":"13875_CR40","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/CIRCRESAHA.115.308166","volume":"118","author":"X Sun","year":"2016","unstructured":"Sun, X. et al. MicroRNA-181b Improves Glucose Homeostasis and Insulin Sensitivity by Regulating Endothelial Function in White Adipose Tissue. Circ Res \n                           118, 810\u2013821, https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.308166 (2016).","journal-title":"Circ Res"},{"key":"13875_CR41","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1007\/s00125-015-3510-2","volume":"58","author":"H Zhu","year":"2015","unstructured":"Zhu, H. & Leung, S. W. Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies. Diabetologia \n                           58, 900\u2013911, https:\/\/doi.org\/10.1007\/s00125-015-3510-2 (2015).","journal-title":"Diabetologia"},{"key":"13875_CR42","doi-asserted-by":"publisher","first-page":"E1681","DOI":"10.1210\/jc.2013-3843","volume":"99","author":"D Santovito","year":"2014","unstructured":"Santovito, D. et al. Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control. J Clin Endocrinol Metab \n                           99, E1681\u20131685, https:\/\/doi.org\/10.1210\/jc.2013-3843 (2014).","journal-title":"J Clin Endocrinol Metab"},{"key":"13875_CR43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1039\/C6MB00596A","volume":"13","author":"YO Nunez Lopez","year":"2016","unstructured":"Nunez Lopez, Y. O., Garufi, G. & Seyhan, A. A. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes. Mol Biosyst \n                           13, 106\u2013121, https:\/\/doi.org\/10.1039\/c6mb00596a (2016).","journal-title":"Mol Biosyst"},{"key":"13875_CR44","doi-asserted-by":"publisher","unstructured":"Delic, D. et al. Characterization of Micro-RNA Changes during the Progression of Type 2 Diabetes in Zucker Diabetic Fatty Rats. Int J Mol Sci \n                           17, doi:https:\/\/doi.org\/10.3390\/ijms17050665 (2016).","DOI":"10.3390\/ijms17050665"},{"key":"13875_CR45","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2174\/1381612822666151112151924","volume":"22","author":"S Gholamin","year":"2016","unstructured":"Gholamin, S. et al. The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment. Curr Pharm Des \n                           22, 397\u2013403 (2016).","journal-title":"Curr Pharm Des"},{"key":"13875_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3978\/j.issn.2072-1439.2015.02.05","volume":"7","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. Circulating miR-499 are novel and sensitive biomarker of acute myocardial infarction. J Thorac Dis \n                           7, 303\u2013308, https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2015.02.05 (2015).","journal-title":"J Thorac Dis"},{"key":"13875_CR47","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1161\/CIRCRESAHA.112.265736","volume":"111","author":"SJ Matkovich","year":"2012","unstructured":"Matkovich, S. J., Hu, Y., Eschenbacher, W. H., Dorn, L. E. & Dorn, G. W. II. Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy. Circ Res \n                           111, 521\u2013531, https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.265736 (2012).","journal-title":"Circ Res"},{"key":"13875_CR48","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.devcel.2009.10.013","volume":"17","author":"E van Rooij","year":"2009","unstructured":"van Rooij, E. et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell \n                           17, 662\u2013673, https:\/\/doi.org\/10.1016\/j.devcel.2009.10.013 (2009).","journal-title":"Dev Cell"},{"key":"13875_CR49","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1007\/s00018-012-1126-y","volume":"69","author":"J Wang","year":"2012","unstructured":"Wang, J. & Yang, X. The function of miRNA in cardiac hypertrophy. Cell Mol Life Sci \n                           69, 3561\u20133570, https:\/\/doi.org\/10.1007\/s00018-012-1126-y (2012).","journal-title":"Cell Mol Life Sci"},{"key":"13875_CR50","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1093\/eurheartj\/ehu346","volume":"35","author":"JP Duong Van Huyen","year":"2014","unstructured":"Duong Van Huyen, J. P. et al. MicroRNAs as non-invasive biomarkers of heart transplant rejection. Eur Heart J \n                           35, 3194\u20133202, https:\/\/doi.org\/10.1093\/eurheartj\/ehu346 (2014).","journal-title":"Eur Heart J"},{"key":"13875_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0672-0","volume":"13","author":"L Fang","year":"2015","unstructured":"Fang, L. et al. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy. J Transl Med \n                           13, 314, https:\/\/doi.org\/10.1186\/s12967-015-0672-0 (2015).","journal-title":"J Transl Med"},{"key":"13875_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep40696","volume":"7","author":"J Beaumont","year":"2017","unstructured":"Beaumont, J. et al. MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure. Sci Rep \n                           7, 40696, https:\/\/doi.org\/10.1038\/srep40696 (2017).","journal-title":"Sci Rep"},{"key":"13875_CR53","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/eurheartj\/ehw250","volume":"38","author":"M Karakas","year":"2017","unstructured":"Karakas, M. et al. Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study. Eur Heart J \n                           38, 516\u2013523, https:\/\/doi.org\/10.1093\/eurheartj\/ehw250 (2017).","journal-title":"Eur Heart J"},{"key":"13875_CR54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/eurjhf\/hfs184","volume":"15","author":"T Seeger","year":"2013","unstructured":"Seeger, T. et al. Immunosenescence-associated microRNAs in age and heart failure. Eur J Heart Fail \n                           15, 385\u2013393, https:\/\/doi.org\/10.1093\/eurjhf\/hfs184 (2013).","journal-title":"Eur J Heart Fail"},{"key":"13875_CR55","unstructured":"Animals, N. R. C. U. C. f. t. U. o. t. G. f. t. C. a. U. o. L. Guide for the Care and Use of Laboratory Animals. 8th edn, (National Academies Press (US), 2011)."},{"key":"13875_CR56","first-page":"H1137","volume":"272","author":"JN Lorenz","year":"1997","unstructured":"Lorenz, J. N. & Robbins, J. Measurement of intraventricular pressure and cardiac performance in the intact closed-chest anesthetized mouse. Am J Physiol \n                           272, H1137\u20131146 (1997).","journal-title":"Am J Physiol"},{"key":"13875_CR57","doi-asserted-by":"crossref","unstructured":"Calligaris, S., Ricca, M. & Conget, P. Cardiac stress test induced by dobutamine and monitored by cardiac catheterization in mice. Journal of visualized Experiments \n                           72, 1\u20136, doi:70.3791\/50050 (2013).","DOI":"10.3791\/50050"},{"key":"13875_CR58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1748-1716.2010.02102.x","volume":"200","author":"A Daniels","year":"2010","unstructured":"Daniels, A. et al. Impaired cardiac functional reserve in type 2 diabetic db\/db mice is associated with metabolic, but not structural, remodelling. Acta Physiol (Oxf) \n                           200, 11\u201322, https:\/\/doi.org\/10.1111\/j.1748-1716.2010.02102.x (2010).","journal-title":"Acta Physiol (Oxf)"},{"key":"13875_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan, J. & Kantharia, N. D. How to calculate sample size in animal studies? J Pharmacol Pharmacother \n                           4, 303\u2013306, https:\/\/doi.org\/10.4103\/0976-500X.119726 (2013).","journal-title":"J Pharmacol Pharmacother"},{"key":"13875_CR60","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","volume":"64","author":"CL Andersen","year":"2004","unstructured":"Andersen, C. L., Jensen, J. L. & Orntoft, T. F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res \n                           64, 5245\u20135250, https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-0496 (2004).","journal-title":"Cancer Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13875-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13875-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13875-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T12:09:22Z","timestamp":1671797362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13875-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,18]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["13875"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-13875-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,18]]},"assertion":[{"value":"31 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13514"}}